Insider Transactions in Q4 2023 at Inari Medical, Inc. (NARI)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2023
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
25,000
-0.59%
|
$1,625,000
$65.2 P/Share
|
|
Dec 14
2023
|
Donald B Milder Director |
SELL
Bona fide gift
|
Indirect |
200,000
-3.35%
|
-
|
|
Dec 12
2023
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,500
-1.86%
|
$403,000
$62.7 P/Share
|
|
Dec 12
2023
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+3.55%
|
$0
$0.46 P/Share
|
|
Dec 04
2023
|
William Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
103,492
+4.7%
|
$0
$0.43 P/Share
|
|
Nov 16
2023
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
37,448
-4.05%
|
$2,209,432
$59.87 P/Share
|
|
Nov 16
2023
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
25,451
-3.74%
|
$1,501,609
$59.87 P/Share
|
|
Nov 15
2023
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
25,000
-0.42%
|
$1,500,000
$60.75 P/Share
|
|
Nov 13
2023
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,500
-1.24%
|
$364,000
$56.2 P/Share
|
|
Nov 13
2023
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+3.55%
|
$0
$0.46 P/Share
|
|
Nov 08
2023
|
Donald B Milder Director |
BUY
Open market or private purchase
|
Indirect |
2,100
+0.03%
|
$109,200
$52.89 P/Share
|
|
Nov 07
2023
|
Donald B Milder Director |
BUY
Open market or private purchase
|
Indirect |
54,000
+1.75%
|
$2,862,000
$53.44 P/Share
|
|
Oct 16
2023
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
25,000
-0.31%
|
$1,400,000
$56.32 P/Share
|
|
Oct 12
2023
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,500
-0.93%
|
$364,000
$56.34 P/Share
|
|
Oct 12
2023
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+3.55%
|
$0
$0.46 P/Share
|
|
Oct 01
2023
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,018
-0.1%
|
$131,170
$65.4 P/Share
|
|
Oct 01
2023
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,867
-0.2%
|
$186,355
$65.4 P/Share
|
|
Oct 01
2023
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,572
-0.31%
|
$102,180
$65.4 P/Share
|
|
Oct 01
2023
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,614
-0.15%
|
$104,910
$65.4 P/Share
|